BRCA1/2 Variants Associated With More Cancers Than Previously Thought
Researchers identified associations between pathogenic variants in BRCA1/2 and 7 cancers.
Diagnosis & Disease Information
Most US Women Undergoing BRCA Testing Not Receiving Genetic Counseling
Most US women undergoing BRCA genetic testing do not receive genetic counseling despite multiple guidelines.
Universal Genetic Testing for Breast Cancer May Not be Good Policy
Although a broad BRCA-1/2 genetic testing program has been suggested for all US women, it is not recommended due to cost and lack of benefit.
Multigene Testing Identifies More Mutations in Breast, Ovarian Cancer
Multigene testing for hereditary breast and/or ovarian cancer (HBOC) identifies more mutations that are likely to change clinical management.
Breast, Ovarian Cancer Risk Varies with BRCA Mutation Location
The risk of breast and ovarian cancer varies with the type and location of BRCA1/2 mutations.
Correlated Spectroscopy Can Identify Changes in BRCA Carriers
Use of localized correlated spectroscopy (COSY) shows significant changes in women with BRCA1 and BRCA2 mutations.
Carboplatin Associated with Better Outcomes than Docetaxel in Advanced BRCA1/2-mutation Breast Cancer
Carboplatin is associated with better outcomes than docetaxel in individuals with BRCA1/2 mutation-harboring breast cancer.
Telephone Support Intervention Beneficial in BRCA Carriers
Reduction in BRCA mutation distress in breast cancer patients, unmet information needs with telephone-based, peer-support program.
Olaparib May Be Effective for Advanced Cancers Associated with BRCA Mutations
Olaparib may be effective for the treatment of numerous advanced cancers caused by BRCA1 and BRCA2 mutations.
Angelina Jolie Coverage Boosted BRCA Testing for Breast Cancer
Celebrity story helped double rates of genetic testing in following six months at one cancer center.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...